MRVI today
$7.70-$0.16 (-2.04%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourStrong Bullish
15 minBullish
5 minStrong Bearish
Daily trend turns down below $5.41
Key levels
Resistance$9.42
Resistance$8.62
Support$7.52
Support$6.80
Latest news & SEC filings
EarningsMaravai LifeSciences holds Q3 2026 earnings call
EarningsMaravai LifeSciences Posts Results for Third Quarter of 2026
GuidanceMaravai LifeSciences lifts FY2026 sales guidance to $212M-$216M
EarningsMaravai LifeSciences posts Q3 adjusted loss of $0.03 per share, topping $0.06 forecast
All MRVI news →About Maravai LifeSciences
Maravai LifeSciences operates through two segments. TriLink manufactures and sells modified nucleic acid products used in research, therapeutic, and vaccine development, along with reagents for protein labeling and detection. Cygnus produces host cell protein and bioprocess impurity detection kits, viral clearance prediction products, and offers custom antibody and assay development services. Customers include pharmaceutical and biotechnology researchers and biologic drug manufacturers.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
What Is the Price Target for MRVI?
SEPT Low Target
$6.50
SEPT Mid Target
$7.25
SEPT High Target
$8.00
Analyst Consensus
$7.25
Is MRVI a Buy or Sell Right Now?
Thesis
- •Revenue growing -28.3% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MRVI.
Start Free Trial →Is MRVI Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$6.33
26
Moat Score
NONE
1/9
Piotroski Score
1.3
Altman Z-Score
What Is Smart Money Doing with MRVI?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Asarpota Rajesh | officer | Sale | 5,466 | $46K | Oct 30, 2026 |
| Brust Bernd | director officer | Sale | 29,250 | $217K | Oct 8, 2026 |
| Asarpota Rajesh | officer | Sale | 5,465 | $42K | Sep 30, 2026 |
| Brust Bernd | director officer | Sale | 29,250 | $214K | Sep 8, 2026 |
| Asarpota Rajesh | officer | Sale | 5,465 | $42K | Aug 31, 2026 |
| ORESHACK KURT | officer | Sale | 25,000 | $127K | Jun 10, 2026 |
| ORESHACK KURT | officer | Sale | 25,000 | $126K | Jun 9, 2026 |
| LUCIER GREGORY T | director | Sale | 46,293 | - | Jun 9, 2026 |
| Brust Bernd | director officer | Sale | 351,001 | $1.8M | Jun 8, 2026 |
| GRAY SUSANNAH | director | Buy | 46,293 | - | May 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MRVI Growth Story
Revenue YoY
-28.3%
3yr Revenue CAGR
-40.5%
EPS Growth YoY
14.29%
FCF Growth YoY
-218.7%
Revenue Trend
ACCELERATING
Dark Pool Trades for MRVI
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MRVI, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:06 | $7.70 | 11,137 | $$86K | SELL |
| 21:00:06 | $7.70 | 12,948 | $$100K | SELL |
| 21:00:06 | $7.70 | 5,200 | $$40K | SELL |
| 21:00:00 | $7.70 | 1,580 | $$12K | BUY |
| 21:00:00 | $7.70 | 2,020 | $$16K | BUY |
5 dark pool trades shown · $$253K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MRVI — frequently asked questions
What is MRVI stock price today?
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) is at $7.70, down 2.04% (-$0.16) at the Nov 11, 2026 close.
Why is MRVI stock moving today?
Latest MRVI news — Nov 4, 2026: Maravai LifeSciences holds Q3 2026 earnings call · Nov 4, 2026: Maravai LifeSciences Posts Results for Third Quarter of 2026
What is the MRVI price target?
The average analyst price target for MRVI is $7.25, ranging from $7 to $8, based on 2 analysts. Latest: UBS maintains on Sep 9, 2026.
What do analysts rate MRVI?
Analyst ratings for MRVI: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did MRVI beat earnings?
MRVI last reported on Aug 6, 2026: EPS -$0.02 vs -$0.04 expected — a beat of 54.0%.
Does MRVI pay a dividend?
MRVI does not currently pay a dividend.
How much debt does MRVI have?
MARAVAI LIFESCIENCES HOLDINGS, INC. reported $147M of debt and $70M of cash (Jun 30, 2026).
What are MRVI support and resistance levels?
Support: $7.52, $6.80, $6.21. Resistance: $8.62, $9.42, $10.03.
What are insiders doing with MRVI?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on MRVI?
Nov 4, 2026: Maravai LifeSciences holds Q3 2026 earnings call · Nov 4, 2026: Maravai LifeSciences Posts Results for Third Quarter of 2026 · Nov 4, 2026: Maravai LifeSciences lifts FY2026 sales guidance to $212M-$216M